NT-501 Encapsulated Cell Therapy

· Stanford University

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NT-501 Encapsulated Cell Therapy, covering 2025-11-04 to 2025-11-04. Get the full timeline:

Most recent: Clinical Trial Update: Dual Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for Glaucoma [Phase 2]